[Relationship between increased oxygen consumption of a muscular area by catecholamines and their vasomotor effects].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology*; D006614:Hindlimb; D007269:Injections, Intra-Arterial; D009132:Muscles / Q000187:drug effects / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects*; D014655:Vascular Resistance / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010100:Oxygen; D009638:Norepinephrine; D004837:Epinephrine
Relations entre l'augmentation de consommation d'oxygene d'un territoire musculaire par les catécholamines et leurs effets vaso-moteurs.